Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type-2 inflammation: a patent evaluation (WO2017/058370)

Expert Opinion on Therapeutic Patents
Jean-Yves Winum

Abstract

Activity modulators of carbonic anhydrases hold great potential for several therapeutic applications against ophthalmologic and neurological disease, cancer, and infectious diseases. The involvement of carbonic anhydrase in the regulation of mast cell response opens new ways for the treatment of mastocytosis, allergic inflammation, and parasite infection. Areas covered: The application claims the use of carbonic anhydrase activity modulators (inhibitors or activators) for treating allergic disease, bacterial infection, fungal infection, viral infection, mastocytosis, or mast cell-mediated inflammation. Expert opinion: Although there is a lack of essential biological data, this patent proposes a new type of applications for carbonic anhydrase inhibitors and deserves further studies. This may lead to new advances in the field of carbonic anhydrase with potential therapeutic implications in the management of type-2 inflammation.

References

Nov 15, 1965·Experientia·L K Korhonen, E Korhonen
Mar 17, 2007·The Journal of Investigative Dermatology·Marijke KamsteegJoost Schalkwijk
Jan 3, 2008·Nature Reviews. Drug Discovery·Claudiu T Supuran
Dec 28, 2010·Biochimica Et Biophysica Acta·Theoharis C TheoharidesDimitrios Kalogeromitros
Mar 7, 2012·Current Pharmaceutical Design·Nikolaos SismanopoulosTheoharis C Theoharides
May 9, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ting WenMarc E Rothenberg
Aug 1, 2015·Future Medicinal Chemistry·Claudiu T Supuran, Jean-Yves Winum
Jan 26, 2016·Journal of Medicinal Chemistry·Vladimir O TalibovU Helena Danielson
Mar 16, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Brian D ModenaAndrew A White
Aug 17, 2016·The Journal of Experimental Medicine·Everett K HenryMark C Siracusa
Oct 27, 2016·Expert Opinion on Drug Discovery·Claudiu T Supuran
Jan 5, 2017·Current Topics in Medicinal Chemistry·Clemente Capasso, Claudiu T Supuran
Feb 6, 2017·Bioorganic & Medicinal Chemistry·Alane B VermelhoClaudiu T Supuran
Apr 22, 2017·Frontiers in Immunology·Fangli Lu, Shiguang Huang
Jun 29, 2017·Immunological Reviews·Masato Kubo
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Emanuela BerrinoFabrizio Carta
Sep 21, 2017·Metabolites·Claudiu T Supuran

❮ Previous
Next ❯

Citations

Sep 16, 2018·Expert Opinion on Therapeutic Patents·Claudiu T Supuran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Bulletins et mémoires de la Société médicale des hôpitaux de Paris
P VIVIEN
Zeitschrift für Vitamin-, Hormon- und Fermentforschung
H KELLER
Hoppe-Seyler's Zeitschrift für physiologische Chemie
H KELLER
© 2022 Meta ULC. All rights reserved